Effect of ramucirumab plus paclitaxel in advanced gastric cancer according to the status of programmed cell death-ligand 1 (PD-L1) expression.

J Gastrointest Oncol · 2023 · PMC10772691 · PMID 38196548

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although the survival outcomes did not differ statistically at cutoff values of 1 and 5, the survival outcomes showed a trend of increasing as the cutoff values increased.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.